Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

285 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Active, not recruiting

Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults

NCT04370054

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • NOW Physical Therapy Mountain View, California, United States
  • Regents of The University of California Oakland, California, United States
  • Clinical and Translational Research Unit (CTRU) Palo Alto, California, United States
  • Lucile Packard Childrens Hospital Palo Alto, California, United States
View all 45 locations
View Trial Details
Active, not recruiting

Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A

NCT04644575

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Orthopaedic Institute for Children Site Number : 8400003 Los Angeles, California, United States
  • Children's Hospital Los Angeles Site Number : 8400009 Los Angeles, California, United States
  • University of California San Diego Site Number : 8400007 San Diego, California, United States
  • University of Florida Health Site Number : 8400008 Gainesville, Florida, United States
View all 85 locations
View Trial Details
Active, not recruiting

Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A

NCT03932201

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • South Alabama Medical Science Foundation Mobile, Alabama, United States
  • Banner MD Anderson Cancer Center Phoenix, Arizona, United States
  • University California Davis Davis, California, United States
  • Orthopaedic Hospital DBA Orthopaedic Institute for Children Los Angeles, California, United States
View all 29 locations
View Trial Details
Active, not recruiting

Study to Learn More About the Safety of Drug Jivi Over a Long Period of Time in Previously Treated Patients With Hemophilia A (Bleeding Disorder Resulting From a Lack of FVIII) Who Are Receiving Jivi Regularly at Their Treating Doctors to Prevent Bleeding

NCT04461639

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Many Locations Multiple Locations, Austria
  • Many Locations Multiple Locations, Germany
  • Many Locations Multiple Locations, Greece
  • Many Locations Multiple Locations, Italy
View Trial Details
Active, not recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations
  • RTI International Research Triangle Park, North Carolina, United States
View Trial Details
Active, not recruiting

A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A

NCT06297655

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Fuyang Hospital Affiliated to Anhui Medical University Fuyang, Anhui, China
  • Anhui Provincial Hospital Hefei, Anhui, China
  • The Second Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • The First Hospital of Lanzhou University Lanzhou, Gansu, China
View Trial Details
Active, not recruiting

UPLC-MS/MS Monitoring of Emicizumab Therapy

NCT04472169

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • CHU de Caen Caen, France
  • Institut Coeur-Poumon, Pôle d'Hématologie-Transfusion, CHU Lille, France
View Trial Details
Active, not recruiting

Phase 3 Study for Efficacy and Safety Outcomes Data in Japanese Patients With Severe Hemophilia A

NCT06224907

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +9 more
Locations
  • Asahikawa Medical University Hospital Hokkaido, Asahikawa, Japan
  • Saitama Medical University Hospital Saitama, Iruma-gun, Japan
  • Nagoya University Hospital Aichi, Nagoya, Japan
  • Tokyo Medical University Hospital Tokyo, Shinjuku-ku, Japan
View Trial Details

Related conditions